Tumor Phenotypes and Correlation to Clinical Outcomes in... | NCT00283530

Studies
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer

NCT00283530

Sponsor

Kentuckiana Cancer Institute

Status

Terminated

Last Update Posted

Jan 20, 2010Estimated

Enrollment

1,000Estimated

Phase

Not provided

Conditions

Cancer

Interventions

Tumor biopsy

Countries

United States

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

ID	Type	Description	Link
CPTAIV-0020-385

Status Module

Record Verification Date

Jan 2010

Overall Recruitment Status or Expanded Access Status

Terminated

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

The PI is no longer with Kentuckiana Cancer Institute. All current subjects completed. No further subjects will be enrolled. Terminated with IRB.

Expanded Access Info

Start Date

May 2003

Primary Completion Date

Not provided

Completion Date

Jul 2009Actual

First Submitted Date

Jan 26, 2006

First Submission Date that Met QC Criteria

Jan 26, 2006

First Posted Date

Jan 30, 2006Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jan 18, 2010

Last Update Posted Date

Jan 20, 2010Estimated

Sponsor/Collaborators Module

Responsible Party, by Official Title

Not provided

Lead Sponsor

Kentuckiana Cancer InstituteOTHER

Collaborators

Not provided

Description Module

Brief Summary

The purpose of this study is to identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.

Detailed Description

To identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

1,000Estimated

Name	Type	Description	Arm Group Labels	Other Names
Tumor biopsy	Procedure

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Diagnosis of cancer receiving chemotherapy
Have had or will have tissue and/or blood samples collected

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Cancer subjects who have or will have tissue and or blood collected.

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Shawn D. Glisson, MD	Kentuckiana Cancer Institute	Study Director

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Kentuckiana Cancer Institute		Louisville	Kentucky	40202	United States

Condition Browse Module

MeSH Terms

ID	Term
D009369	Neoplasms

Ancestor Terms

Not provided

Browse Leaves

Not provided

Browse Branches

Not provided